Jefferies Upgrades Eastman Chemical (EMN) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
SunTrust Upgrades Eastman Chemical (EMN) to Buy
November 4, 2014 6:51 AM ESTSunTrust Robinson Humphrey upgraded Eastman Chemical (NYSE: EMN) from Neutral to Buy with a price target of $95.00.
For an analyst ratings summary and ratings history on Eastman Chemical click here. For more ratings news on Eastman Chemical click here.
Shares of Eastman Chemical closed at $82.03 yesterday.
... MoreEastman Chemical (EMN) Results Solid, Transformation Continues - BofA/Merrill Lynch
October 31, 2014 12:17 PM EDTBofA/Merrill Lynch analyst Kevin McCarthy reiterated a Buy rating and $95 price target on Eastman Chemical (NYSE: EMN) following Q3 results with modest upside on the top and bottom-line and guidance to the high end.
The analyst notes management continues to transform... More
Eastman Chemical (EMN) Tops Q3 EPS by 9c
October 30, 2014 5:16 PM EDTEastman Chemical (NYSE: EMN) reported Q3 EPS of $1.89, $0.09 better than the analyst estimate of $1.80. Revenue for the quarter came in at $2.41 billion versus the consensus estimate of $2.41 billion.
For earnings history and earnings-related data on Eastman Chemical (EMN) click here.
... More